D’Angelo Advisory was founded to help science-driven organizations build commercial systems as rigorous as their research. I work with biotech and research platform companies navigating growth, inflection, or strategic transition, bringing structured commercial thinking to complex scientific environments.

Over the past decade, I have led North American go-to-market strategy, enterprise pipeline development, and partnership initiatives across proteomics, multi-omics, and data platform companies. My experience spans early-stage commercialization, revenue architecture, scientific positioning, and enterprise sales strategy within pharma, biotech, CRO, and academic markets.

I am particularly drawn to organizations operating at the intersection of advanced science and scalable infrastructure. My work focuses on clarifying market positioning, strengthening revenue systems, and aligning commercial execution with long-term strategic objectives.

Commercial growth in life sciences requires more than sales execution. It requires fluency in science, disciplined process design, and a deep understanding of how research organizations evaluate value and risk. My approach blends those elements to help ambitious teams grow deliberately and sustainably.